CONDUIT-HF: Continuous Observation and Non-invasive Detection with Unified Interfaces for Trusted agents for Heart Failure

CONDUIT-HF, led by Oura with Wake Forest University, will validate ring-based physiology in heart failure patients to build a continuous congestive heart failure (CHF) prediction index with an FDA SaMD pathway and an open, vendor-neutral standard for feeding wearable data into AI agents, at under 2% of the cost of implantable monitors. As the ring needs no specialist to implant and ships directly to patients, this approach can reach rural and home-bound patients and scale across entire health systems.CONDUIT-HF, led by Oura, will validate ring-based physiology in heart failure patients to build a continuous congestive heart failure (CHF) prediction index with an FDA SaMD pathway, and will create an open, vendor-neutral standard for feeding wearable data into AI agents, offering non-invasive congestion monitoring at less than 2% of the cost of implantable monitors.

Back to Award Directory